CEO Johnson on entrepreneurship, upcoming MedtechColor Pitch Contest; Krum handicaps medtech Q4
In this episode of the DeviceTalks Weekly Podcast, Angelique Johnson, CEO of MEMstim, shares her “accidental entrepreneur” story and how it has enabled her the help others pursuing the same dream.
Johnson, co-founder of MedtechColor, an organization seeking to further the advancement of people of color in the medical device industry, details the groups goals and invites entrepreneurs of color to apply for the group’s Pitch Contest.
The deadline is Feb. 5. Go to medtechcolor.org for more information.
Truist Security Managing Director Kaila Krum answers questions about medtech’s Q4 performance, diving deeper on Stryker and other companies.
Krum also shares details on a survey conducted by the research team that sought to answer the question – when will hospitals start seeing elective patients again.
Pharma Editor Brian Buntz returns to the podcast to tell his story of his 10 days wearing a continuous glucose monitor from Dexcom.
Buntz wrote about the experience here, but he shares more details on the podcast. https://www.drugdeliverybusiness.com/how-cgms-can-inspire-lifestyle-changes/
Finally, Chris Newmarker, executive editor of life sciences, delivers his #newmarkersnewsmakers featuring Titan, Mylan, Zimmer Biomet, and Butterfly.
Johnson, co-founder of MedtechColor, an organization seeking to further the advancement of people of color in the medical device industry, details the groups goals and invites entrepreneurs of color to apply for the group’s Pitch Contest.
The deadline is Feb. 5. Go to medtechcolor.org for more information.
Truist Security Managing Director Kaila Krum answers questions about medtech’s Q4 performance, diving deeper on Stryker and other companies.
Krum also shares details on a survey conducted by the research team that sought to answer the question – when will hospitals start seeing elective patients again.
Pharma Editor Brian Buntz returns to the podcast to tell his story of his 10 days wearing a continuous glucose monitor from Dexcom.
Buntz wrote about the experience here, but he shares more details on the podcast. https://www.drugdeliverybusiness.com/how-cgms-can-inspire-lifestyle-changes/
Finally, Chris Newmarker, executive editor of life sciences, delivers his #newmarkersnewsmakers featuring Titan, Mylan, Zimmer Biomet, and Butterfly.
Activity